The CFAR/CSG Clinical Core will provide a mechanism for multidisciplinary collaboration among basic, clinical and behavioral scientistic to address innovative research questions important to a better understanding of HIV disease pathogenesis or better methods of diagnosis or treatment of HIV disease. Specifically, this Core will facilitate translation between basic and clinical HIV research by providing 1) expert clinical research consultation to assist basic scientists in developing the most appropriate protocol design for testing their specific hypotheses, 2) experienced clinical research staff personnel to recruit subjects and implement protocols thus providing basic scientists in developing the most appropriate specimens needed for specific hypothesis testing, 3) behavioral expertise to basic scientists and clinical researchers to assist them in conceptualizing and implementing research protocols and interpreting findings, and 4) behavioral scientists the opportunity to test hypotheses relevant to behavioral research questions in clinical populations. The expert clinical consultation service includes an associate professor of medicine infectious diseases/clinical trials specialist a research pharmacist/coordinator, an associate professor of biostatistics, who will serve as coordinator of the Behavioral Research Unit within in the Clinical Core, each with 8 or more years of academic, HIV-related clinical research experience at UCSF. The Core Director and Research Coordinator already coordinate a dynamic HIV clinical research program as San Francisco General Hospital that is integrated into an outpatient clinic with a patients base of greater than 3,000 individuals at various stages of HIV disease. The Core Director, Study Coordinator and scientists in the Behavioral Research Unit already collaborate on a number of multidisciplinary studies to test specific hypotheses that emerge from basic research. The full Clinical Core service will provide consultation with the investigators to determine optimal study design, preparation of a written study protocol and subjects informed consent form, obtaining IRB approval and ;maintaining required IRBG correspondence for the protocol, recruitment of subjects, obtaining and providing investigator with all protocol-specific specimens are relevant clinical data, long-term storage of specimens in an ultra-low temperature specimen repository, and behavioral assessments. These services will enable different investigators, and multidisciplinary teams of investigators, to efficiently explore innovative hypotheses, ranging from clinical studies of the molecular biology of HIV to behavioral studies of cofactors in treatment response among women and minorities.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI027763-09
Application #
6234917
Study Section
Project Start
1997-03-01
Project End
1998-02-28
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
9
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Chammartin, Frédérique; Zürcher, Kathrin; Keiser, Olivia et al. (2018) Outcomes of Patients Lost to Follow-up in African Antiretroviral Therapy Programs: Individual Patient Data Meta-analysis. Clin Infect Dis 67:1643-1652
Pulugulla, Sree H; Packard, Thomas A; Galloway, Nicole L K et al. (2018) Distinct mechanisms regulate IL1B gene transcription in lymphoid CD4 T cells and monocytes. Cytokine 111:373-381
Mohamed, Tamer M A; Ang, Yen-Sin; Radzinsky, Ethan et al. (2018) Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration. Cell 173:104-116.e12
Bengtson, Angela M; Pence, Brian W; Eaton, Ellen F et al. (2018) Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015. Antivir Ther 23:363-372
Vardi, Noam; Chaturvedi, Sonali; Weinberger, Leor S (2018) Feedback-mediated signal conversion promotes viral fitness. Proc Natl Acad Sci U S A 115:E8803-E8810
Carrico, Adam W; Flentje, Annesa; Kober, Kord et al. (2018) Recent stimulant use and leukocyte gene expression in methamphetamine users with treated HIV infection. Brain Behav Immun 71:108-115
Tymejczyk, Olga; Brazier, Ellen; Yiannoutsos, Constantin et al. (2018) HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: A metaregression analysis of programmatic data from 22 countries. PLoS Med 15:e1002534
Sauceda, John A; Lisha, Nadra E; Neilands, Torsten B et al. (2018) Cognitive-affective depressive symptoms and substance use among Latino and non-Latino White patients in HIV care: an analysis of the CFAR network of integrated clinical systems cohort. J Behav Med :
Carrico, Adam W; Cherenack, Emily M; Roach, Margaret E et al. (2018) Substance-associated elevations in monocyte activation among methamphetamine users with treated HIV infection. AIDS 32:767-771
AIDS-defining Cancer Project Working Group of IeDEA, COHERE in EuroCoord (2018) Non-Hodgkin lymphoma risk in adults living with HIV across five continents. AIDS 32:2777-2786

Showing the most recent 10 out of 1541 publications